First volunteers set to get experimental Lyme Disease vaccine in large clinical trial

By Gizmodo
| August 10, 2022

Thousands of people in the U.S. and Europe will receive a shot developed partly by Pfizer, designed to protect against the tickborne illness.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...